Lv1
38 积分 2025-01-09 加入
Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy
13天前
已完结
Sirtuins and tumor immunity: mechanistic insights, immunotherapy prospects, and therapeutic horizons
15天前
已完结
PARP7 as a new target for activating anti-tumor immunity in cancer
16天前
已完结
Novel Carbamate-Based o-aminobenzamide Derivatives as Potent Antigastric Carcinoma Agents via Disrupting NAD+ Salvage Synthesis
27天前
已完结
TMET-19. Targeting NQO1 and the NAD+ Salvage Pathway: A Novel Therapeutic Strategy for Glioblastoma
27天前
已关闭
Discovery of Potent PDEδ/NAMPT Dual Inhibitors: Preclinical Evaluation in KRAS Mutant Pancreatic Cancer Cells
1个月前
已完结
Dual-Target Inhibitors Based on COX-2: A Review from Medicinal Chemistry Perspectives
1个月前
已完结
Medicinal Chemistry of Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors
1个月前
已完结
Dual PARP/NAMPT Inhibitors for BRCA Wild-Type Triple-Negative Breast Cancer: Disrupting Homologous Recombination Repair and Activating Antitumor Immunity
1个月前
已完结
Targeting Metabolic and pH Regulatory Pathways in Cancer via Dual Inhibition of Nicotinamide Phosphoribosyltransferase and Carbonic Anhydrases IX and XII
1个月前
已完结
皖公网安备34019202002308
